In the above article [Benamar K, Geller EB, and Adler MW (2008) J Pharmacol Exp Ther325:641–645], the chemical composition for AMD 3100 is incorrect in the abstract and abbreviation list. The correct definition is 1,1′-[1,4-phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] octohydrobromide dihydrate.
The online version of this article has been corrected in departure from the print version.
The authors regret this error and apologize for any confusion or inconvenience it may have caused.
- The American Society for Pharmacology and Experimental Therapeutics